- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bukwang Pharm (003000)
Assess today's live Bukwang Pharm (003000) share price, performance and insights using our live Seoul: 003000 stock exchange data.
Analyse the historical data and Bukwang Pharm share price performance charts on this page. Our technical summary section provides analysis on Bukwang Pharm share price buy/sell indicators using real-time data (or discuss the Bukwang Pharm (003000) stock price today with other investors in the Bukwang Pharm KS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KS 003000 share price (ISIN: KR7003000007) to enhance your trading decisions with our free investment tools and resources.
What Is the Bukwang Pharm Share Price Today?
The Bukwang Pharm share price today is 5,420.
What Is the Stock Symbol for Bukwang Pharm
The stock symbol (or 'ticker') for Bukwang Pharm is "003000."
What Stock Exchange Does Bukwang Pharm Trade On?
Bukwang Pharm is listed and trades on the Seoul stock exchange.
Is Bukwang Pharm a Good Stock to Buy?
Determining whether Bukwang Pharm—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Bukwang Pharm share price performance charts on this page. Our technical summary section provides analysis on Bukwang Pharm share price buy/sell indicators using real-time data (or discuss the Bukwang Pharm (003000) stock price today with other investors in the Bukwang Pharm KS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KS 003000 share price (ISIN: KR7003000007) to enhance your trading decisions with our free investment tools and resources.
What Is the Bukwang Pharm Share Price Today?
The Bukwang Pharm share price today is 5,420.
What Is the Stock Symbol for Bukwang Pharm
The stock symbol (or 'ticker') for Bukwang Pharm is "003000."
What Stock Exchange Does Bukwang Pharm Trade On?
Bukwang Pharm is listed and trades on the Seoul stock exchange.
Is Bukwang Pharm a Good Stock to Buy?
Determining whether Bukwang Pharm—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Seoul
Currency in KRW
5,420
+150(+2.85%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5,290
5,630
52 wk Range
3,200
9,890
003000 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5,2905,630
52 wk Range
3,2009,890
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.37%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.37%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
003000 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Earnings
Latest Release
08/05/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare 003000 to Peers and Sector
Metrics to compare | 003000 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship003000PeersSector | |
|---|---|---|---|---|
P/E Ratio | 42.6x | −4.0x | −0.5x | |
PEG Ratio | 0.08 | 0.03 | 0.00 | |
Price/Book | 1.6x | 1.0x | 2.6x | |
Price / LTM Sales | 2.7x | 0.8x | 3.1x | |
Upside (Analyst Target) | - | 54.5% | 53.0% | |
Fair Value Upside | Unlock | 3.1% | 6.3% | Unlock |
Bukwang Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products in South Korea and internationally. It offers its products in oral solid dosage forms, injections, oral solutions, external solutions, and ointments. The company also provides ethical drugs, including drugs for treating diabetic peripheral neuropathy, hypothyroidism, toxic liver disease, chronic hepatitis, liver cirrhosis, and iron-deficiency anemia; over-the-counter drugs, such as fever and pain relief medication, gastrointestinal medication, cold medication, laxatives for constipation, collagen supplements, multivitamin supplements, mouthwash, topical gels, oral health supplements, and omega-3 supplements; and personal products comprising toothpastes, toothbrushes, and other oral care products; nutraceuticals; health functional foods; and quasi drugs. In addition, it offers products for various threptic areas, including endocrinology, gastroenterology, cardiology, oncology, central nervous system, iron supplements, neuropsychiatry, respiratory/allergy, dermatology, urology, and other treatment areas. Further, the company’s development pipeline comprises Lurasidone for the treatment of schizophrenia and bipolar depression; JM-010, for treating dyskinesia in parkinson’s disease; SOL-804, which is used for the treatment of metastatic castration resistant prostate cancer; AhR Inhibitor for solid tumors; PKR Inhibitor for neurodegenerative disorders; and PD Program for parkinson’s disease. Bukwang Pharmaceutical Co., Ltd. was founded in 1960 and is headquartered in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Bukwang Pharm (Seoul: 003000) Share Price Today?
The Bukwang Pharm stock price today is 5,420 KRW.
What Stock Exchange Does Bukwang Pharm (003000) Trade On?
Bukwang Pharm is listed and trades on the Seoul Stock Exchange.
What Is the Ticker (Stock Symbol) for Bukwang Pharm?
The stock symbol (also called a 'ticker') for Bukwang Pharm is "003000."
Does Bukwang Pharm Pay Dividends? What’s The Current 003000 Dividend Yield?
Yes, 003000 Pays Dividends to its Shareholders. The current Bukwang Pharm dividend yield is 2.37%.
What Is the Current Bukwang Pharm Market Capitalisation?
As of today, Bukwang Pharm (Seoul: 003000) market cap is 534.76B KRW.
What Is Bukwang Pharm's (003000) Earnings Per Share (TTM)?
The Bukwang Pharm EPS is currently 152 (Trailing Twelve Months).
When Is the Next Bukwang Pharm Earnings Date?
Bukwang Pharm's next earnings report will be released on 08/05/2026.
Is 003000 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Bukwang Pharm moving averages and other technical indicators, the daily buy/sell signal for 003000 stock is Strong Sell.
How Many Times Has Bukwang Pharm Stock Split?
Bukwang Pharm has split 16 times. (See the 003000 stock split history page for full effective split date and price information.)
How Many Employees Does Bukwang Pharm Have?
Bukwang Pharm has 615 employees, based on their latest Companies House report.
What is the current trading status of Bukwang Pharm (Seoul: 003000)?
As of 23/05/2026, Bukwang Pharm (003000) is trading at a share price of 5,420 KRW, with a previous close of 5,270 KRW. The stock has fluctuated within a day range of 5,290 KRW to 5,630 KRW, while its 52-week range spans from 3,200 KRW to 9,890 KRW.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.